BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19953432)

  • 1. [Multiple cavernous hemangioma progressing in size in a cirrhotic liver].
    Henninger B; Bale R; Schocke M
    Rofo; 2010 Apr; 182(4):357-9. PubMed ID: 19953432
    [No Abstract]   [Full Text] [Related]  

  • 2. MRI findings of hepatocellular carcinoma.
    Wiwanitkit V
    Magn Reson Imaging; 2011 Feb; 29(2):303. PubMed ID: 21129874
    [No Abstract]   [Full Text] [Related]  

  • 3. MRI findings of rapidly progressive hepatocellular carcinoma.
    Kierans AS; Leonardou P; Hayashi P; Brubaker LM; Elazzazi M; Shaikh F; Semelka RC
    Magn Reson Imaging; 2010 Jul; 28(6):790-6. PubMed ID: 20427139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of hepatic metastases from colorectal cancer: prospective evaluation of gray scale US versus SonoVue® low mechanical index real time-enhanced US as compared with multidetector-CT or Gd-BOPTA-MRI.
    Cantisani V; Ricci P; Erturk M; Pagliara E; Drudi F; Calliada F; Mortele K; D'Ambrosio U; Marigliano C; Catalano C; Marin D; Di Seri M; Longo F; Passariello R
    Ultraschall Med; 2010 Oct; 31(5):500-5. PubMed ID: 20408122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MRI imaging of liver neoplasma].
    Mio A; Suzuki T; Suzaki K
    Rinsho Hoshasen; 1989 Dec; 34(13):1579-84. PubMed ID: 2560082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rosai-Dorfman disease with bilateral kidney involvement: morphologic image characteristics of a very rare organ manifestation].
    Possekel AK; Feuerlein S; Juchems MS
    Rofo; 2010 Jan; 182(1):71-2. PubMed ID: 19676020
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver lesion characterization: the wrong choice of contrast agent can mislead the diagnosis of hemangioma.
    Pradella S; Lucarini S; Colagrande S
    AJR Am J Roentgenol; 2012 Nov; 199(5):W662. PubMed ID: 23096214
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemangioma in the cirrhotic liver: diagnosis and natural history.
    Brancatelli G; Federle MP; Blachar A; Grazioli L
    Radiology; 2001 Apr; 219(1):69-74. PubMed ID: 11274536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadobenate dimeglumine-enhanced liver MR imaging in cirrhotic patients: quantitative and qualitative comparison of 1-hour and 3-hour delayed images.
    Jeong WK; Byun JH; Lee SS; Won HJ; Kim KW; Shin YM; Kim PN; Lee MG
    J Magn Reson Imaging; 2011 Apr; 33(4):889-97. PubMed ID: 21448954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cirrhosis and pre-neoplastic lesions.
    Grazioli L; Olivetti L; Orlando E
    Abdom Imaging; 2012 Apr; 37(2):188-214. PubMed ID: 22297506
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging.
    Schneider G; Altmeyer K; Kirchin MA; Seidel R; Grazioli L; Morana G; Saini S
    Invest Radiol; 2007 Feb; 42(2):105-15. PubMed ID: 17220728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of multiple cavernous hemangioma of the liver with prednisolone.
    Vlachos P; Anoussakis C; Liakakos D
    Helv Paediatr Acta; 1974 Nov; 29(5):439-41. PubMed ID: 4452643
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis.
    Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
    Clin Imaging; 2008; 32(6):453-9. PubMed ID: 19006774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perilesional enhancement of liver cavernous hemangiomas in magnetic resonance imaging.
    Sousa MS; Ramalho M; Herédia V; Matos AP; Palas J; Jeon YH; Afonso D; Semelka RC
    Abdom Imaging; 2014 Aug; 39(4):722-30. PubMed ID: 24531350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast enhanced MR-guided biopsy of hepatocellular carcinoma.
    König CW; Trübenbach J; Fritz J; Lauer UM; Claussen CD; Pereira PL
    Abdom Imaging; 2004; 29(1):71-6. PubMed ID: 15160756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Perfusion MR imaging of the liver with a vascular contrast agent].
    Leporq B; Beuf O; Pilleul F
    J Radiol; 2011 Mar; 92(3):257-61. PubMed ID: 21501767
    [No Abstract]   [Full Text] [Related]  

  • 17. Cavernous hemangiomas in patients with chronic liver disease: MR imaging findings.
    Mastropasqua M; Kanematsu M; Leonardou P; Braga L; Woosley JT; Semelka RC
    Magn Reson Imaging; 2004 Jan; 22(1):15-8. PubMed ID: 14972389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant reduction of the echogenicity of the compressed cavernous hemangioma.
    Choji K; Shinohara M; Nojima T; Kusumoto K; Une Y; Glazer RN; Isomatsu T
    Acta Radiol; 1988; 29(3):317-20. PubMed ID: 2968101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of exophytic hepatic hemangioma mimicking adrenal tumor.
    Maèkawa S; Mizutani Y; Terachi T; Okada Y; Yoshida O
    Hinyokika Kiyo; 1997 Feb; 43(2):123-6. PubMed ID: 9086347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.